Research Grants Awarded

Reseach grants support Minnesota scientific and medical research that has the potential to translate to clinical advances in regenerative medicine. Grants typically open every September. Learn more about how to apply for a grant by reading our frequently asked questions. 

 

View research grants awarded by year.
Smoot Headshot Official (1).jpeg
Rory Smoot, MD
Augmenting Liver Regeneration at the Single Cell Level
This application examines the mechanisms by which targeting the molecule YAP with medications can facilitate liver regeneration. We propose that YAP…
2022-2024
Joseph Metzger, PhD
Joseph Metzger, PhD
Advancing a genetically edited biosensor platform in human induced pluripotent stem cell-derived cardiac muscle for personalized medicine and drug discovery
This proposal focuses on leveraging advances in cardiac stem cell biology to forge new therapeutic modalities for combating heart disease, the…
2022-2024
Qiuying Liu (1).jpeg
Qiuying Liu, PhD
Mechanistic studies on a congenital hydrocephalus causing mutation in Trim71
Congenital hydrocephalus is a major cause of childhood morbidity. Mutations in Trim71, a conserved stem-cell-specific RNA-binding protein, cause this…
2022-2024
James Dutton Headshot 2020.jpeg
James Dutton, PhD
Pre-clinical evaluation of drug treatments to prevent vision loss from Dry Age-Related Macular Degeneration using patient-derived iPSC-RPE
Dry Age related macular degeneration is a chronic disease of aging that causes progressive loss of vision due to damage to the RPE cell layer in the…
2022-2024
1 Krych Aaron 2020.jpeg
Aaron Krych, MD
MSC facilitated cartilage recycling for hip defects
The overall goal of this study is to test the safety and feasibility for a one-stage cartilage restoration procedure for symptomatic defects of the…
2022-2024
Dr. Siegler
Elizabeth Siegler, PhD
Bioengineering of Mesenchymal Stromal Cells for Regenerative Medicine
Mesenchymal stromal cells (MSCs) have intrinsic immunosuppressive and regenerative properties. We seek to engineer MSCs with artificial receptors to…
2021-2023
Dr. Kostallari
Enis Kostallari, PhD
Epigenetic inhibition of inflammation in alcoholic hepatitis
Public Health Relevance: Alcoholic Hepatitis (AH) is a severe liver disease and is a leading cause of morbidity and mortality in the United States of…
2021-2023
Dr. Abdel
Matthew Abdel, MD
First-in-class pharmacotherapies for arthrofibrosis
Joint stiffening (arthrofibrosis) is a debilitating complication with limited treatment options that is observed in a substantial subset of patients…
2021-2023
Dr. Scarisbrick
Isobel Scarisbrick, PhD
Pharmacoregeneration for Chronic Spinal Cord Injury
Our goal is to develop a new treatment strategy that improves outcomes in individuals with chronic spinal cord injury. Studies will contribute to the…
2021-2023
Dr. Ogle
Brenda Ogle, PhD
A humanized model of hypertrophic cardiomyopathy (HCM) to study disease onset and progression in response to volumetric pressure loads
The clinical prognosis for patients with hypertrophic cardiomyopathy (HCM) is very poor and the only long-term alternative is heart transplant. Our…
2021-2023
Dr. Low
Walter Low, PhD
Unlocking Chimeric Competency for Regenerative Medicine
The goal of this research is to facilitate the generation of human organs and cells for transplantation and repair of the human body. The generation…
2021-2023
Dr. Junge
Harald Junge, PhD
Restoring vascular and neural functions in mouse models of retinal disease
Retinal vascular diseases, e.g., diabetic retinopathy, are a leading cause of blindness and place a significant burden on individual patients as well…
2021-2023